Literature DB >> 7059089

Allergic bronchopulmonary aspergillosis: staging as an aid to management.

R Patterson, P A Greenberger, R C Radin, M Roberts.   

Abstract

Five stages of allergic bronchopulmonary aspergillosis were identified in 40 patients studied for several years. The stages are acute, remission, exacerbation, corticosteroid-dependent asthma, and fibrotic. The acute stage has all criteria of the disease and responds to prednisone. The remission stage is free from significant asthma or exacerbations. The exacerbation stage has recurrent flares of acute allergic bronchopulmonary aspergillosis. The corticosteroid-dependent asthma stage may have recurrent exacerbations of allergic bronchopulmonary aspergillosis and severe asthma. The fibrotic stage is an advanced stage of radiographic abnormalities with asthma, irreversible and partially reversible obstructive pulmonary function changes, and poor prognosis. Measurement of IgE and IgG antibodies against Aspergillus fumigatus is of diagnostic value in all stages.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7059089     DOI: 10.7326/0003-4819-96-3-286

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  34 in total

Review 1.  Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.

Authors:  A P Knutsen; R G Slavin
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

2.  Corticosteroid treatment and prognosis in pulmonary eosinophilia.

Authors:  S Capewell; B J Chapman; F Alexander; A P Greening; G K Crompton
Journal:  Thorax       Date:  1989-11       Impact factor: 9.139

Review 3.  Histopathologic diagnosis of fungal infections in the 21st century.

Authors:  Jeannette Guarner; Mary E Brandt
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

4.  A phase 1/1b study of PUR1900, an inhaled formulation of itraconazole, in healthy volunteers and asthmatics to study safety, tolerability and pharmacokinetics.

Authors:  David L Hava; Lisa Tan; Patrick Johnson; Aidan K Curran; Jason Perry; Steve Kramer; Katie Kane; Pauline Bedwell; Gary Layton; Clarie Swann; Dennis Henderson; Naimat Khan; Lucy Connor; Litza McKenzie; Dave Singh; James Roach
Journal:  Br J Clin Pharmacol       Date:  2020-01-16       Impact factor: 4.335

Review 5.  Allergic bronchopulmonary aspergillosis.

Authors:  R G Slavin
Journal:  Clin Rev Allergy       Date:  1985-05

6.  Allergic bronchopulmonary aspergillosis in Italian cystic fibrosis patients: prevalence and percentage of positive tests in the employed diagnostic criteria.

Authors:  G Taccetti; E Procopio; L Marianelli; S Campana
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

Review 7.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

Review 8.  Allergic bronchopulmonary aspergillosis.

Authors:  Richard B Moss
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

Review 9.  Asthma and Fungus: Role in Allergic Bronchopulmonary Aspergillosis (ABPA) and Other Conditions.

Authors:  Meenu Singh; Nandini Paul; Shreya Singh; Gyan Ranjan Nayak
Journal:  Indian J Pediatr       Date:  2018-03-17       Impact factor: 1.967

10.  Trial of ketoconazole in non-invasive pulmonary aspergillosis.

Authors:  D J Shale; J A Faux; D J Lane
Journal:  Thorax       Date:  1987-01       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.